Cargando…

Autoimmune pancreatitis can develop into chronic pancreatitis

Autoimmune pancreatitis (AIP) has been recognized as a distinct type of pancreatitis that is possibly caused by autoimmune mechanisms. AIP is characterized by high serum IgG4 and IgG4-positive plasma cell infiltration in affected pancreatic tissue. Acute phase AIP responds favorably to corticosteroi...

Descripción completa

Detalles Bibliográficos
Autores principales: Maruyama, Masahiro, Watanabe, Takayuki, Kanai, Keita, Oguchi, Takaya, Asano, Jumpei, Ito, Tetsuya, Ozaki, Yayoi, Muraki, Takashi, Hamano, Hideaki, Arakura, Norikazu, Kawa, Shigeyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038704/
https://www.ncbi.nlm.nih.gov/pubmed/24884922
http://dx.doi.org/10.1186/1750-1172-9-77
_version_ 1782318386458394624
author Maruyama, Masahiro
Watanabe, Takayuki
Kanai, Keita
Oguchi, Takaya
Asano, Jumpei
Ito, Tetsuya
Ozaki, Yayoi
Muraki, Takashi
Hamano, Hideaki
Arakura, Norikazu
Kawa, Shigeyuki
author_facet Maruyama, Masahiro
Watanabe, Takayuki
Kanai, Keita
Oguchi, Takaya
Asano, Jumpei
Ito, Tetsuya
Ozaki, Yayoi
Muraki, Takashi
Hamano, Hideaki
Arakura, Norikazu
Kawa, Shigeyuki
author_sort Maruyama, Masahiro
collection PubMed
description Autoimmune pancreatitis (AIP) has been recognized as a distinct type of pancreatitis that is possibly caused by autoimmune mechanisms. AIP is characterized by high serum IgG4 and IgG4-positive plasma cell infiltration in affected pancreatic tissue. Acute phase AIP responds favorably to corticosteroid therapy and results in the amelioration of clinical findings. However, the long-term prognosis and outcome of AIP remain unclear. We have proposed a working hypothesis that AIP can develop into ordinary chronic pancreatitis resembling alcoholic pancreatitis over a long-term course based on several clinical findings, most notably frequent pancreatic stone formation. In this review article, we describe a series of study results to confirm our hypothesis and clarify that: 1) pancreatic calcification in AIP is closely associated with disease recurrence; 2) advanced stage AIP might have earlier been included in ordinary chronic pancreatitis; 3) approximately 40% of AIP patients experience pancreatic stone formation over a long-term course, for which a primary risk factor is narrowing of both Wirsung’s and Santorini’s ducts; and 4) nearly 20% of AIP patients progress to confirmed chronic pancreatitis according to the revised Japanese Clinical Diagnostic Criteria, with independent risk factors being pancreatic head swelling and non-narrowing of the pancreatic body duct.
format Online
Article
Text
id pubmed-4038704
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40387042014-05-31 Autoimmune pancreatitis can develop into chronic pancreatitis Maruyama, Masahiro Watanabe, Takayuki Kanai, Keita Oguchi, Takaya Asano, Jumpei Ito, Tetsuya Ozaki, Yayoi Muraki, Takashi Hamano, Hideaki Arakura, Norikazu Kawa, Shigeyuki Orphanet J Rare Dis Review Autoimmune pancreatitis (AIP) has been recognized as a distinct type of pancreatitis that is possibly caused by autoimmune mechanisms. AIP is characterized by high serum IgG4 and IgG4-positive plasma cell infiltration in affected pancreatic tissue. Acute phase AIP responds favorably to corticosteroid therapy and results in the amelioration of clinical findings. However, the long-term prognosis and outcome of AIP remain unclear. We have proposed a working hypothesis that AIP can develop into ordinary chronic pancreatitis resembling alcoholic pancreatitis over a long-term course based on several clinical findings, most notably frequent pancreatic stone formation. In this review article, we describe a series of study results to confirm our hypothesis and clarify that: 1) pancreatic calcification in AIP is closely associated with disease recurrence; 2) advanced stage AIP might have earlier been included in ordinary chronic pancreatitis; 3) approximately 40% of AIP patients experience pancreatic stone formation over a long-term course, for which a primary risk factor is narrowing of both Wirsung’s and Santorini’s ducts; and 4) nearly 20% of AIP patients progress to confirmed chronic pancreatitis according to the revised Japanese Clinical Diagnostic Criteria, with independent risk factors being pancreatic head swelling and non-narrowing of the pancreatic body duct. BioMed Central 2014-05-21 /pmc/articles/PMC4038704/ /pubmed/24884922 http://dx.doi.org/10.1186/1750-1172-9-77 Text en Copyright © 2014 Maruyama et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Maruyama, Masahiro
Watanabe, Takayuki
Kanai, Keita
Oguchi, Takaya
Asano, Jumpei
Ito, Tetsuya
Ozaki, Yayoi
Muraki, Takashi
Hamano, Hideaki
Arakura, Norikazu
Kawa, Shigeyuki
Autoimmune pancreatitis can develop into chronic pancreatitis
title Autoimmune pancreatitis can develop into chronic pancreatitis
title_full Autoimmune pancreatitis can develop into chronic pancreatitis
title_fullStr Autoimmune pancreatitis can develop into chronic pancreatitis
title_full_unstemmed Autoimmune pancreatitis can develop into chronic pancreatitis
title_short Autoimmune pancreatitis can develop into chronic pancreatitis
title_sort autoimmune pancreatitis can develop into chronic pancreatitis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038704/
https://www.ncbi.nlm.nih.gov/pubmed/24884922
http://dx.doi.org/10.1186/1750-1172-9-77
work_keys_str_mv AT maruyamamasahiro autoimmunepancreatitiscandevelopintochronicpancreatitis
AT watanabetakayuki autoimmunepancreatitiscandevelopintochronicpancreatitis
AT kanaikeita autoimmunepancreatitiscandevelopintochronicpancreatitis
AT oguchitakaya autoimmunepancreatitiscandevelopintochronicpancreatitis
AT asanojumpei autoimmunepancreatitiscandevelopintochronicpancreatitis
AT itotetsuya autoimmunepancreatitiscandevelopintochronicpancreatitis
AT ozakiyayoi autoimmunepancreatitiscandevelopintochronicpancreatitis
AT murakitakashi autoimmunepancreatitiscandevelopintochronicpancreatitis
AT hamanohideaki autoimmunepancreatitiscandevelopintochronicpancreatitis
AT arakuranorikazu autoimmunepancreatitiscandevelopintochronicpancreatitis
AT kawashigeyuki autoimmunepancreatitiscandevelopintochronicpancreatitis